These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

481 related articles for article (PubMed ID: 31771057)

  • 1. Neuropathologic Correlates of White Matter Hyperintensities in a Community-Based Cohort of Older Adults.
    Arfanakis K; Evia AM; Leurgans SE; Cardoso LFC; Kulkarni A; Alqam N; Lopes LF; Vieira D; Bennett DA; Schneider JA
    J Alzheimers Dis; 2020; 73(1):333-345. PubMed ID: 31771057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuropathologic and Cognitive Correlates of Enlarged Perivascular Spaces in a Community-Based Cohort of Older Adults.
    Javierre-Petit C; Schneider JA; Kapasi A; Makkinejad N; Tamhane AA; Leurgans SE; Mehta RI; Barnes LL; Bennett DA; Arfanakis K
    Stroke; 2020 Sep; 51(9):2825-2833. PubMed ID: 32757750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Can white matter hyperintensities based Fazekas visual assessment scales inform about Alzheimer's disease pathology in the population?
    Pradeep A; Raghavan S; Przybelski SA; Preboske GM; Schwarz CG; Lowe VJ; Knopman DS; Petersen RC; Jack CR; Graff-Radford J; Cogswell PM; Vemuri P
    Alzheimers Res Ther; 2024 Jul; 16(1):157. PubMed ID: 38987827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. White matter hyperintensities and cognition across different Alzheimer's biomarker profiles.
    Lam S; Lipton RB; Harvey DJ; Zammit AR; Ezzati A;
    J Am Geriatr Soc; 2021 Jul; 69(7):1906-1915. PubMed ID: 33891712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CSF amyloid is a consistent predictor of white matter hyperintensities across the disease course from aging to Alzheimer's disease.
    Walsh P; Sudre CH; Fiford CM; Ryan NS; Lashley T; Frost C; Barnes J;
    Neurobiol Aging; 2020 Jul; 91():5-14. PubMed ID: 32305782
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
    Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
    Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alzheimer-Related Cerebrovascular Disease in Down Syndrome.
    Lao PJ; Gutierrez J; Keator D; Rizvi B; Banerjee A; Igwe KC; Laing KK; Sathishkumar M; Moni F; Andrews H; Krinsky-McHale S; Head E; Lee JH; Lai F; Yassa MA; Rosas HD; Silverman W; Lott IT; Schupf N; Brickman AM
    Ann Neurol; 2020 Dec; 88(6):1165-1177. PubMed ID: 32944999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. White Matter Hyperintensities in Mild Cognitive Impairment and Lower Risk of Cognitive Decline.
    Nolze-Charron G; Mouiha A; Duchesne S; Bocti C;
    J Alzheimers Dis; 2015; 46(4):855-62. PubMed ID: 26402625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Associations of Amyloid Burden, White Matter Hyperintensities, and Hippocampal Volume With Cognitive Trajectories in the 90+ Study.
    Wang J; Ackley S; Woodworth DC; Sajjadi SA; Decarli CS; Fletcher EF; Glymour MM; Jiang L; Kawas C; Corrada MM
    Neurology; 2024 Aug; 103(3):e209665. PubMed ID: 39008782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between brain amyloid deposition and longitudinal changes of white matter hyperintensities.
    Cha WJ; Yi D; Ahn H; Byun MS; Chang YY; Choi JM; Kim K; Choi H; Jung G; Kang KM; Sohn CH; Lee YS; Kim YK; Lee DY
    Alzheimers Res Ther; 2024 Mar; 16(1):50. PubMed ID: 38454444
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association of White Matter Hyperintensities With Pathology and Progression of Parkinsonism in Aging.
    Oveisgharan S; Yu L; Poole VN; Evia AM; Barnes LL; Schneider JA; Arfanakis K; Bennett DA; Buchman AS
    JAMA Neurol; 2021 Dec; 78(12):1494-1502. PubMed ID: 34724033
    [TBL] [Abstract][Full Text] [Related]  

  • 12. White matter hyperintensity distribution differences in aging and neurodegenerative disease cohorts.
    Dadar M; Mahmoud S; Zhernovaia M; Camicioli R; Maranzano J; Duchesne S;
    Neuroimage Clin; 2022; 36():103204. PubMed ID: 36155321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. White matter damage due to vascular, tau, and TDP-43 pathologies and its relevance to cognition.
    Raghavan S; Przybelski SA; Reid RI; Lesnick TG; Ramanan VK; Botha H; Matchett BJ; Murray ME; Reichard RR; Knopman DS; Graff-Radford J; Jones DT; Lowe VJ; Mielke MM; Machulda MM; Petersen RC; Kantarci K; Whitwell JL; Josephs KA; Jack CR; Vemuri P
    Acta Neuropathol Commun; 2022 Feb; 10(1):16. PubMed ID: 35123591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small vessel cerebrovascular disease is associated with cognition in prospective Alzheimer's clinical trial participants.
    Morales CD; Cotton-Samuel D; Lao PJ; Chang JF; Pyne JD; Alshikho MJ; Lippert RV; Bista K; Hale C; Edwards NC; Igwe KC; Deters K; Zimmerman ME; Brickman AM
    Alzheimers Res Ther; 2024 Feb; 16(1):25. PubMed ID: 38308344
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders.
    Kim YE; Lim JS; Suh CH; Heo H; Roh JH; Cheong EN; Lee Y; Kim JW; Lee JH
    Alzheimers Res Ther; 2024 Aug; 16(1):185. PubMed ID: 39148136
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Postmortem MRI: a novel window into the neurobiology of late life cognitive decline.
    Dawe RJ; Yu L; Leurgans SE; Schneider JA; Buchman AS; Arfanakis K; Bennett DA; Boyle PA
    Neurobiol Aging; 2016 Sep; 45():169-177. PubMed ID: 27459937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo MRI transverse relaxation in community based older persons with and without Alzheimer's dementia.
    Yu L; Dawe RJ; Buchman AS; Boyle PA; Schneider JA; Arfanakis K; Bennett DA
    Behav Brain Res; 2017 Mar; 322(Pt B):233-240. PubMed ID: 27596378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Automated White Matter Hyperintensity Segmentation Using Bayesian Model Selection: Assessment and Correlations with Cognitive Change.
    Fiford CM; Sudre CH; Pemberton H; Walsh P; Manning E; Malone IB; Nicholas J; Bouvy WH; Carmichael OT; Biessels GJ; Cardoso MJ; Barnes J;
    Neuroinformatics; 2020 Jun; 18(3):429-449. PubMed ID: 32062817
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Contribution of Cerebral Vascular Neuropathology to Mild Stage of Alzheimer's Dementia Using the NACC Database.
    Liu Y; Chan DK; Crawford JD; Sachdev PS; Braidy N
    Curr Alzheimer Res; 2020; 17(13):1167-1176. PubMed ID: 33583381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of Asymmetrical White Matter Hyperintensities and Apolipoprotein E4 on Cognitive Impairment.
    Low A; Ng KP; Chander RJ; Wong B; Kandiah N
    J Alzheimers Dis; 2019; 70(3):953-964. PubMed ID: 31306121
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.